Latest Eisai Stories
WASHINGTON, Nov. 7, 2014 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that David J.
Focus on the Completion of Phase 3 Clinical Trials and Commercial Preparations for Telotristat Etiprate in Carcinoid Syndrome THE WOODLANDS, Texas, Nov.
-- Trial Met Primary Efficacy Endpoint with Statistical Significance After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Eisai Inc.
TAIPEI, Oct. 30, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc.
-- Trial Met Primary Safety Objective After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 28, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc.
Winner to be Featured in Third Book of Epilepsy Education Comic Book Series WOODCLIFF LAKE, N.J., Oct.
RnRMarketResearch.com adds “Partial Seizure – Pipeline Review, H2 2014” to its store.
WOODCLIFF LAKE, N.J., Oct. 14, 2014 /PRNewswire/ -- Eisai Inc. announced today that the U.S.
Recognizing unique patient needs on Metastatic Breast Cancer Awareness Day, mbcInfoCenter.com offers important metastatic breast cancer resources in one convenient place WOODCLIFF LAKE, N.J.,
WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 13, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc.
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.